Advertisement
UK markets close in 4 hours 5 minutes

  • FTSE 100

    7,826.49
    -50.56 (-0.64%)
     

  • FTSE 250

    19,272.25
    -178.42 (-0.92%)
     

  • AIM

    741.12
    -4.17 (-0.56%)
     

  • GBP/EUR

    1.1676
    -0.0007 (-0.06%)
     

  • GBP/USD

    1.2437
    -0.0002 (-0.01%)
     

  • Bitcoin GBP

    52,164.10
    +1,628.66 (+3.22%)
     

  • CMC Crypto 200

    1,337.09
    +24.46 (+1.90%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CRUDE OIL

    81.85
    -0.88 (-1.06%)
     

  • GOLD FUTURES

    2,387.50
    -10.50 (-0.44%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,700.38
    -137.02 (-0.77%)
     

  • CAC 40

    7,994.18
    -29.08 (-0.36%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Why Envision Healthcare (EVHC) Could Be Positioned for a Slump

Zacks Equity Research
Updated

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Envision Healthcare Corporation EVHC, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in EVHC.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen 10 estimates moving down in the past 30 days, compared with no upward revisions. This trend has caused the consensus estimate to trend lower, going from $3.39 a share a month ago to its current level of $2.85.

Also, for the current quarter, Envision Healthcarehas seen six downward estimate revisions versus no revisions in the opposite direction, dragging the consensus estimate down to 56 cents a share from 99 cents over the past 30 days.  

ADVERTISEMENT

The stock also has seen some pretty dismal trading lately, as the share price has dropped 37.6% in the past month.

Envision Healthcare Corporation Price and Consensus

Envision Healthcare Corporation Price and Consensus | Envision Healthcare Corporation Quote

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the Medical industry, you may instead consider a better-ranked stock - Amedisys, Inc. AMED. The stock currently holds a Zacks Rank #2 (Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Amedisys Inc (AMED) : Free Stock Analysis Report
 
Envision Healthcare Corporation (EVHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.